Former Members

• Eunkwa Ko, Postdoc at Yale University
• Cliferson Thivierge, Reserch Chemist at SiVance, LLC, a subsidiary of Milliken & Company
• Orlando Flores, graduate student at University of University of Guanajuato in Mexico
• Fang Xie, postdoctoral associate at Utah State
• Ye Zhu, Postdoc at the University of Wisconsin
• Jiney Jose, Postdoc at the University of Texas at Austin
• Liangxing Wu, Research Scientist at Incyte
• Junyan Han, University of Pittsburgh (postdoctoral associate with Professor Peter Wipf)
• Jian Zhao, postdoctoral associate at Scripps Research Institute
• Yuichiro Ueno, DOJINDO
• Destardi Moye-Sherman, Merck & Co., Inc.
• Binh T. Nguyen, BASF Corp.
• Jian Zhang, Amgen
• Jing Liu, postdoctoral associate at Harvard Medical School
• Juan Castro, Applied Sciences Chemist at Lynntech, Inc.
• BoRam Lee, graduate student at Ecole Polytechnique Federale de Lausanne, Switzerland
• Lingling Li, Texas Engineering Experiment Station, TAMU
• Yu-Chin Li, Texas Engineering Experiment Station, TAMU
• Andrey Malakhov, BioNumerik Pharmaceuticals, Inc.
• Juan Rodriguez-Poirier, Pacific Lutheran University-Tacoma
• Jianguang Zhou, China
• Zebin Xia, Burnham Institute
• Mike Welch, Array BioPharma
• Zhicheng Wang, Johnson & Johnson
• Chi-wai Wan, Hong Kong
• Wilfred van der Donk, Professor at University of Illinois
• Reiko Totani, Patent law, Japan
• Lars H. Thoresen, Cengent Therapeutics
• Long Thai, Paradigm Partners
• Aroonsiri Shitangkoon, professor at Chulalongkorn University, Thailand
• Hunwoo Shin, BK-Biopharmaceuticals
• Sam Reyes, postdoctoral associate at North Carolina State University
• Rakesh Bandichhor, Senior Scientist, Dr. Reddy's Laboratories Hyderabad, India
• Ramesh Raghavachari, U.S. FDA
• Mark Powell, Johnson & Johnson
• Alexander Porte, Pfizer
• Marc Perry, Professor at Point Loma Nazarene University
• Mookda Pattarawarapan, professor at Chiang Mai University
• Biman Pal, Arena Pharmaceuticals
• Mike Ohlmeyer, professor at Mt. Sinai School of Medicine
• Carlos Martinez, Sigma Custom Products
• Suresh Manthati
• Genliang Lu, Molecular Insight Pharmaceuticals
• Lee T. Liu, Development Center for Biotechnology
• Dongyeol Lim, professor at Sejong University
• Wen Li, Finnegan, Henderson, Farabow, Garrett & Dunner LLP
• Shiming Li, Hoffmann-La Roche Inc.
• Stefano Levizzani, Italy
• H. Boon Lee, Cancer Research Initiatives Foundation, Malaysia
• Benjamin Lane, Biogen
• Ernest Nnanabu
• Tia-Liu Lee, Pharm. R&D Labs, Taiwan
• Sang Lam, Albany Molecular Research
• ChiHyo Park
• Heejin Kim, Enanta Pharmaceuticals Inc.
• Chun-Yen Ke, Purdue University
• Guan-sheng Jiao, Hawaii Biotech, Inc.
• Luyong Jiang, ChemBridge Research Inc.
• Inhye Ham, research associate at Kyung-Hee University
• Yangbo Feng, research associate at Scripps Florida
• Xiuhua Cui, Dow Chemicals
• Jiong Chen, Sundia Medi Tech Company; ChemRx
• Dianjun Chen, Acme Bioscience
• Dave Chaplin, Dow Cambridge
• Armin Burghart, BASF Corp.
• Josue Alfaro-Lopez, Amylin Pharmaceuticals; ChemRx
• Yu Li Angell, Albemarle Corp.
• Lee Jennings, Wyeth-Ayerst Research
• Marcel Jaspars, professor at University of Aberdeen, Scotland
• Jacutin-Porte Swanee, Bristol-Meyers Squibb
• Javier Ibarzo, Almirall Chemical Development; University of Barcelona, Spain
• Duen-Ren Hou, professor at National University of Kaosiung, Taiwan
• Koc-Kan Ho, SuperGen, Inc.
• Ian Henderson, Director of Chemistry at Ligand Pharmaceuticals
• Jin Wook Han, professor at Hanyang University, South Korea